Aims Tumor electric fields therapy (TTFields) is emerging as a novel anti‐cancer
physiotherapy. Despite recent breakthroughs of TTFields in glioma treatment, the average …

Objective Glioma is a devastating disease lacking effective treatment. Tumor electric field
therapy is emerging as a novel non‐invasive therapy. The current study evaluates the …

Background Tumor Treating Fields (TTFields) therapy is a non-invasive, loco-regional, anti-
mitotic treatment modality that targets rapidly dividing cancerous cells, utilizing low intensity …

Background Glioblastoma multiforme (GBM) is an aggressive malignant tumor with a high
mortality rate and is the most prevalent primary intracranial tumor that remains incurable …

Simple Summary Glioblastoma (GBM) is the most common malignant primary brain tumor.
Although the standard of care, including maximal resection, concurrent radiotherapy with …

Despite major advances in therapy, cancer continues to be a leading cause of mortality. In
addition, toxicities of traditional therapies pose a significant challenge to tolerability and …

Introduction: Local control is fundamental, both for the curative as well as the palliative
treatment of cancer. Tumor treating fields (TTFields) are low intensity (1–2 V/cm) …

As the most recent innovation in cancer therapy that utilizes properties of the
electromagnetic spectrum, tumor treating fields (TTFields) are non-invasive alternating …

Introduction As a novel treatment modality, tumor treating fields (TTFields) exert low-
intensity, medium-frequency electric fields on tumor cells. TTFields' effectiveness and safety …

Exposing cancer cells to alternating electric fields of 100-300 kHz frequency and 1-4 V/cm
strength has been shown to significantly reduce cancer growth in cell culture and in human …